900 Efficacy and safety of apixaban compared to warfarin for prevention of stroke and systemic embolism in 18,201 patients with atrial fibrillation: Primary results of the ARISTOTLE Trial
Publication
, Conference
Ezekowitz, J; Dorian, P; Granger, C; Alexander, J; Lopes, R; Hanna, M; Geraldes, M; Wallentin, L
Published in: Canadian Journal of Cardiology
September 2011
Duke Scholars
Published In
Canadian Journal of Cardiology
DOI
ISSN
0828-282X
Publication Date
September 2011
Volume
27
Issue
5
Start / End Page
S334 / S334
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology
Citation
APA
Chicago
ICMJE
MLA
NLM
Ezekowitz, J., Dorian, P., Granger, C., Alexander, J., Lopes, R., Hanna, M., … Wallentin, L. (2011). 900 Efficacy and safety of apixaban compared to warfarin for prevention of stroke and systemic embolism in 18,201 patients with atrial fibrillation: Primary results of the ARISTOTLE Trial. In Canadian Journal of Cardiology (Vol. 27, pp. S334–S334). Elsevier BV. https://doi.org/10.1016/j.cjca.2011.07.611
Ezekowitz, J., P. Dorian, C. Granger, J. Alexander, R. Lopes, M. Hanna, M. Geraldes, and L. Wallentin. “900 Efficacy and safety of apixaban compared to warfarin for prevention of stroke and systemic embolism in 18,201 patients with atrial fibrillation: Primary results of the ARISTOTLE Trial.” In Canadian Journal of Cardiology, 27:S334–S334. Elsevier BV, 2011. https://doi.org/10.1016/j.cjca.2011.07.611.
Ezekowitz J, Dorian P, Granger C, Alexander J, Lopes R, Hanna M, et al. 900 Efficacy and safety of apixaban compared to warfarin for prevention of stroke and systemic embolism in 18,201 patients with atrial fibrillation: Primary results of the ARISTOTLE Trial. In: Canadian Journal of Cardiology. Elsevier BV; 2011. p. S334–S334.
Ezekowitz, J., et al. “900 Efficacy and safety of apixaban compared to warfarin for prevention of stroke and systemic embolism in 18,201 patients with atrial fibrillation: Primary results of the ARISTOTLE Trial.” Canadian Journal of Cardiology, vol. 27, no. 5, Elsevier BV, 2011, pp. S334–S334. Crossref, doi:10.1016/j.cjca.2011.07.611.
Ezekowitz J, Dorian P, Granger C, Alexander J, Lopes R, Hanna M, Geraldes M, Wallentin L. 900 Efficacy and safety of apixaban compared to warfarin for prevention of stroke and systemic embolism in 18,201 patients with atrial fibrillation: Primary results of the ARISTOTLE Trial. Canadian Journal of Cardiology. Elsevier BV; 2011. p. S334–S334.
Published In
Canadian Journal of Cardiology
DOI
ISSN
0828-282X
Publication Date
September 2011
Volume
27
Issue
5
Start / End Page
S334 / S334
Publisher
Elsevier BV
Related Subject Headings
- Cardiovascular System & Hematology
- 3201 Cardiovascular medicine and haematology
- 1102 Cardiorespiratory Medicine and Haematology